Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?Berta Pernas, Marta Grandal, Sonia Pertega, et al.
Antiviral Therapy|July 8, 2022
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019)Belén Alejos, Cristina Díez, María J Galindo, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2019
Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra LeoneGeorge A Yendewa, Foday Sahr, Sulaiman Lakoh, et al.
Journal of Medical Virology|July 18, 2013
Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration wavesFederico A Di Lello, Karin Neukam, Manuel Parra-Sanchez, et al.
Journal of Medical Virology|July 20, 2004
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failureEva Poveda, Berta Rodés, Jean-Louis Labernardière, et al.
AIDS (London, England)|January 9, 2010
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance databaseEva Poveda, Lourdes Anta, José Luis Blanco, et al.
Journal of Medical Virology|February 11, 2018
Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategiesMarta Grandal, Berta Pernas, Andrés Tabernilla, et al.
Antiviral Therapy|June 21, 2011
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in SpainPaula Tuma, Juan Antonio Pineda, Pablo Labarga, et al.
AIDS (London, England)|August 23, 2011
Hepatitis delta in HIV-infected individuals in EuropeVincent Soriano, Daniel Grint, Antonella d'Arminio Monforte, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2014
HIV-2 viral tropism influences CD4+ T cell count regardless of viral loadAna Treviño, Vicente Soriano, Eva Poveda, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?Berta Pernas, Marta Grandal, Sonia Pertega, et al.
Antiviral Therapy|July 8, 2022
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019)Belén Alejos, Cristina Díez, María J Galindo, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2019
Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra LeoneGeorge A Yendewa, Foday Sahr, Sulaiman Lakoh, et al.
Journal of Medical Virology|July 18, 2013
Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration wavesFederico A Di Lello, Karin Neukam, Manuel Parra-Sanchez, et al.
Journal of Medical Virology|July 20, 2004
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failureEva Poveda, Berta Rodés, Jean-Louis Labernardière, et al.
AIDS (London, England)|January 9, 2010
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance databaseEva Poveda, Lourdes Anta, José Luis Blanco, et al.
Journal of Medical Virology|February 11, 2018
Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategiesMarta Grandal, Berta Pernas, Andrés Tabernilla, et al.
Antiviral Therapy|June 21, 2011
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in SpainPaula Tuma, Juan Antonio Pineda, Pablo Labarga, et al.
AIDS (London, England)|August 23, 2011
Hepatitis delta in HIV-infected individuals in EuropeVincent Soriano, Daniel Grint, Antonella d'Arminio Monforte, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2014
HIV-2 viral tropism influences CD4+ T cell count regardless of viral loadAna Treviño, Vicente Soriano, Eva Poveda, et al.
Pageof 15